Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong Ignacio Faus?

Ignacio Faus

Partner, Head of Transactions and Restructuring In Spain

KPMG

Direct Phone: +34 *** ** ** **direct phone

Email: i***@***.es

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

KPMG

Spain

Find other employees at this company (177,951)

Background Information

Employment History

Chief Strategy Officer

KIPP Foundation


Investment Director

Permira Limited


Business Development Director and Licensing

Uriach Corporation


Director

KPMG LLP


Business Development Director and Licensing

Adamant Biomedical Investments AG


Expert Reviewer

Europe Unlimited S.A


Chief Executive Officer

Palau Pharma , S.A.


Affiliations

Genmedica

Shareholder and Chief Executive Officer ► Turnarounds│Divestitures│Cost Control│Venture Financing│Strategic Alliances


See

Board Member


Ferrer

Strategic Innovation Advisor ► Operational Efficiency│Spin-Outs and Carve-Outs│Organizational Planning


European Biopharmaceutical Enterprises

Board Member


Biopharmaceutical companies

Board Member


CNRS-Bristol Myers Squibb Research Center

EMBO Fellow


Education

BS

chemistry

Bowdoin College


MBA

J.L.Kellogg Graduate School of Management , Northwestern University


Ph.D.

biochemistry

Indiana University


degree

Business Administration ( Finance

Deusto University


Web References(59 Total References)


Management | Genmedica Therapeutics

www.genmedica.com [cached]

Ignacio Faus - Chief Executive Officer (CEO)
See Board of Directors


www.genmedica.com

Ignacio Faus - CEO
Dr. Faus' early years of scientific research focused on the regulation of gene expression at the transcriptional level. He was an EMBO (European Molecular Biology Organization) fellow at the CNRS-Bristol Myers Squibb Research Center in Strasbourg (France), and later set up his own research group at the Howard Hughes Medical Institute at the University of Chicago (USA). After a career in academic research he transitioned to industry, where he held positions in several pharmaceutical companies. In 2006 Dr. Faus was one of the founders of Palau Pharma, a Barcelona-based biotech company focused on developing new drugs for the treatment of autoimmune and inflammation-based pathologies. The company raised 48 M € in several venture-backed financing rounds and executed a myriad of licensing agreements with global pharmaceutical companies. He successfully divested the company in 2013, selling its assets to some of the largest global pharmaceutical companies in the world. The laboratories and personnel of Palau Pharma were integrated in the structure of the LEITAT Technology Park as a new Drug Discovery & Development company, Draconis Pharma. Dr. Faus received a Ph.D. in Biochemistry from Indiana University (USA) and an MBA from the Kellogg Graduate School of Management, Northwestern University (USA). He also holds a PDG from IESE (Barcelona).


www.genmedica.com

Ignacio Faus - CEO
Dr. Faus's early years of scientific research focused on the regulation of gene expression at the transcriptional level. He was an EMBO (European Molecular Biology Organization) fellow at the CNRS-Bristol Myers Squibb Research Center in Strasbourg (France), and later set up his own research group at the Howard Hughes Medical Institute at the University of Chicago (USA). After a career in academic research he transitioned to industry, where he held positions in several pharmaceutical companies. In 2006 Dr. Faus was one of the founders of Palau Pharma, a Barcelona-based biotech company focused on developing new drugs for the treatment of autoimmune and inflammation-based pathologies. The company raised 46 M € in several venture-backed financing rounds and executed a myriad of licensing agreements with global pharmaceutical companies. He successfully divested the company in 2013, selling its assets to some of the largest global pharmaceutical companies in the world. The laboratories and personnel of Palau Pharma were integrated in the structure of the LEITAT Technology Park as a new Drug Discovery & Development company, Draconis Pharma. Dr. Faus received a Ph.D. in Biochemistry from Indiana University (USA) and an MBA from the J.L.Kellogg Graduate School of Management, Northwestern University (USA). He also holds a PDG from IESE (Barcelona).


Board of Directors

www.genmedica.com [cached]

Ignacio Faus - CEO
Dr. Faus's early years of scientific research focused on the regulation of gene expression at the transcriptional level. He was an EMBO (European Molecular Biology Organization) fellow at the CNRS-Bristol Myers Squibb Research Center in Strasbourg (France), and later set up his own research group at the Howard Hughes Medical Institute at the University of Chicago (USA). After a career in academic research he transitioned to industry, where he held positions in several pharmaceutical companies. In 2006 Dr. Faus was one of the founders of Palau Pharma, a Barcelona-based biotech company focused on developing new drugs for the treatment of autoimmune and inflammation-based pathologies. The company raised 46 M € in several venture-backed financing rounds and executed a myriad of licensing agreements with global pharmaceutical companies. Hesuccessfully divested the company in 2013, selling its assets to some of the largest global pharmaceutical companies in the world. The laboratories and personnel of Palau Pharma were integrated in the structure of the LEITAT Technology Park as a new Drug Discovery & Development company, Draconis Pharma. Dr. Faus received a Ph.D. in Biochemistry from Indiana University (USA) and an MBA from the J.L.Kellogg Graduate School of Management, Northwestern University (USA). He also holds a PDG from IESE (Barcelona).


Management

www.genmedica.com [cached]

Ignacio Faus- Chief Executive Officer (CEO)
See Board of Directors


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory